Mazor Robotics Ltd. (MZOR) Downgraded to “Sell” at Zacks Investment Research
According to Zacks, “Mazor Robotics Ltd. is engaged in the development, production and marketing of medical devices for surgical procedures in the fields of orthopedics and neurosurgery. It offers Renaissance(TM), a surgical robotic system to conduct spine surgeries with less radiation. The company operates in the United States, Eastern Europe, Western Europe and Asia. Mazor Robotics Ltd. is based in Caesarea, Israel. “
Other analysts have also recently issued reports about the company. Standpoint Research initiated coverage on Mazor Robotics in a research note on Friday, July 8th. They set a buy rating and a $30.00 target price for the company. Needham & Company LLC reaffirmed a hold rating on shares of Mazor Robotics in a research report on Thursday, July 7th. B. Riley began coverage on Mazor Robotics in a research report on Thursday, October 6th. They set a neutral rating and a $25.00 price target for the company. Finally, Barclays PLC upped their price target on Mazor Robotics from $24.00 to $28.00 and gave the stock an overweight rating in a research report on Tuesday, October 11th. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus price target of $26.25.
Mazor Robotics (NASDAQ:MZOR) traded down 0.55% during trading on Friday, hitting $23.62. 27,901 shares of the stock were exchanged. Mazor Robotics has a 1-year low of $8.31 and a 1-year high of $26.55. The firm’s 50 day moving average price is $23.40 and its 200-day moving average price is $18.37. The stock’s market cap is $511.92 million.
Mazor Robotics (NASDAQ:MZOR) last posted its earnings results on Tuesday, August 2nd. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02. Mazor Robotics had a negative return on equity of 42.30% and a negative net margin of 60.75%. The business earned $8.30 million during the quarter, compared to analysts’ expectations of $8.51 million. During the same period in the prior year, the business earned ($0.05) EPS. Mazor Robotics’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, analysts anticipate that Mazor Robotics will post ($0.71) EPS for the current year.
Several large investors have recently added to or reduced their stakes in MZOR. EAM Investors LLC bought a new stake in Mazor Robotics during the second quarter valued at approximately $2,348,000. Iguana Healthcare Management LLC increased its stake in Mazor Robotics by 384.6% in the first quarter. Iguana Healthcare Management LLC now owns 121,151 shares of the company’s stock valued at $1,507,000 after buying an additional 96,151 shares during the last quarter. Candriam Luxembourg S.C.A. bought a new stake in Mazor Robotics during the second quarter valued at approximately $1,079,000. Menta Capital LLC increased its stake in Mazor Robotics by 81.9% in the first quarter. Menta Capital LLC now owns 37,482 shares of the company’s stock valued at $466,000 after buying an additional 16,879 shares during the last quarter. Finally, Cookson Peirce & Co. Inc. bought a new stake in Mazor Robotics during the second quarter valued at approximately $192,000. 18.72% of the stock is owned by institutional investors.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.